Yali Zheng Selected Research

Yali Zheng Research Topics

Disease

11	Pneumonia (Pneumonitis) 01/2024 - 01/2018
7	Neoplasms (Cancer) 10/2022 - 01/2010
6	Glioma (Gliomas) 06/2014 - 07/2011
5	Infections 01/2024 - 11/2017
4	Obesity 01/2023 - 01/2010
4	Inflammation (Inflammations) 01/2023 - 01/2020
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2023 - 01/2020
3	Hypoxia (Hypoxemia) 01/2022 - 01/2010
3	Septic Shock (Toxic Shock Syndrome) 01/2020 - 10/2016
3	Glioblastoma (Glioblastoma Multiforme) 06/2014 - 07/2011
2	Dyslipidemias (Dyslipidemia) 01/2023 - 01/2010
2	Major Depressive Disorder (Major Depressive Disorders) 01/2023 - 01/2023
2	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2022 - 01/2022
2	Confusion (Bewilderment) 01/2021 - 01/2018
2	Human Influenza (Influenza) 01/2021 - 01/2021
2	Hypertension (High Blood Pressure) 01/2021 - 01/2010
2	COVID-19 01/2021 - 01/2021
2	Proteinuria 01/2021 - 01/2002
1	Wounds and Injuries (Trauma) 05/2024
1	Cognitive Dysfunction 05/2024
1	Diabetic Nephropathies (Diabetic Nephropathy) 03/2024
1	Insulin Resistance 03/2024
1	Schizophrenia (Dementia Praecox) 12/2023
1	Thrombosis (Thrombus) 11/2023
1	Myopia 01/2023
1	Blast Crisis (Blast Phase) 01/2023
1	Donnai-Barrow syndrome 01/2023
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2023
1	Type 2 Diabetes Mellitus (MODY) 01/2023
1	Lung Neoplasms (Lung Cancer) 10/2022
1	Hyperthermia 10/2022
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2022
1	Breakthrough Infections 01/2022
1	Kidney Diseases (Kidney Disease) 01/2021

Drug/Important Bio-Agent (IBA)

5	CytokinesIBA 12/2023 - 01/2020
4	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2010
3	Interleukin-6 (Interleukin 6)IBA 12/2023 - 01/2021
3	Proteins (Proteins, Gene)FDA Link 11/2023 - 06/2006
3	16S Ribosomal RNAIBA 01/2023 - 01/2022
3	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2020
3	Peptides (Polypeptides)IBA 01/2021 - 01/2012
3	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 06/2014 - 07/2011
3	Matrix Metalloproteinase 2 (Gelatinase A)IBA 05/2012 - 01/2012
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 03/2024 - 12/2022
2	Indicators and Reagents (Reagents)IBA 01/2023 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2021
2	LipidsIBA 01/2021 - 05/2019
2	AlbuminsIBA 01/2021 - 05/2019
2	Urea (Carbamide)FDA LinkGeneric 01/2021 - 01/2018
2	EpitopesIBA 01/2021 - 01/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 04/2020 - 05/2019
2	CateninsIBA 06/2014 - 05/2012
2	Lithium ChlorideIBA 06/2014 - 01/2012
2	Scorpion Venoms (Scorpion Venom)IBA 05/2012 - 01/2012
1	SilverIBA 05/2024
1	IonsIBA 05/2024
1	HydrogelsIBA 05/2024
1	rheinIBA 05/2024
1	Antipsychotic Agents (Antipsychotics)IBA 05/2024
1	Long Noncoding RNAIBA 03/2024
1	Monoclonal AntibodiesIBA 01/2024
1	Programmed Cell Death 1 ReceptorIBA 12/2023
1	LigandsIBA 12/2023
1	PolymersIBA 11/2023
1	Tyrosine Kinase InhibitorsIBA 01/2023
1	Azacitidine (5 Azacytidine)FDA Link 01/2023
1	SuspensionsIBA 01/2023
1	venetoclaxIBA 01/2023
1	Low Density Lipoprotein Receptor-Related Protein-2IBA 01/2023
1	ethanoxyhexamercarbideIBA 01/2023
1	Cyclin-Dependent Kinase 5IBA 01/2023
1	NLR ProteinsIBA 12/2022
1	Interleukin-10 (Interleukin 10)IBA 12/2022
1	nobiletinIBA 12/2022
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 10/2022
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 10/2022
1	Photosensitizing Agents (Photosensitizers)IBA 10/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2022
1	neuromedin NIBA 10/2022
1	cinnamyl alcoholIBA 10/2022
1	EnkephalinsIBA 10/2022
1	Phospholipids (Phosphatides)FDA LinkGeneric 04/2022
1	LysophospholipidsIBA 04/2022
1	Pyruvic Acid (Pyruvate)IBA 01/2022
1	Inactivated VaccinesIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Amino Acids FDA Link 01/2022
1	Interleukin-17 (Interleukin 17)IBA 01/2021
1	ThrombospondinsIBA 01/2021
1	DisintegrinsIBA 01/2021
1	AntibodiesIBA 01/2021
1	Interleukin-22 (IL-22)IBA 01/2021

Therapy/Procedure

7	Therapeutics 01/2023 - 01/2012
2	Artificial Respiration (Mechanical Ventilation) 01/2020 - 11/2017
2	Drug Therapy (Chemotherapy) 01/2012 - 07/2011
1	Intraperitoneal Injections 01/2024
1	Photothermal Therapy 10/2022
1	Photochemotherapy (Photodynamic Therapy) 10/2022
1	Hematopoietic Stem Cell Transplantation 01/2022
1	Aftercare (After-Treatment) 01/2021